by Eric Christianson | Oct 8, 2023 | Women’s and Men’s Health Medication and Disease State Clinical Pearls
I received a question the other day about EPT (expedited partner therapy) and STD management. State laws vary so be sure to check with your board of pharmacy. In this blog post, we will describe EPT and share what we have learned when looking at the rules from two...
by Eric Christianson | Oct 1, 2023 | Cardiovascular Medication and Disease State Clinical Pearls
Let’s tackle a question I recently received. What’s the difference between Cardizem CD Versus LA? We will look closely at these two Cardizem formulations, as it seems many of us have questioned their clinical differences. Both Cardizem CD and Cardizem LA...
by Eric Christianson | Sep 27, 2023 | Cardiovascular Medication and Disease State Clinical Pearls
Angiotensin Receptor Blockers are one of the most commonly used drug classes to manage hypertension. Many clinicians prefer using these medications even over ACE inhibitors to reduce the risk of running into the ACE inhibitor-related cough. This is the primary...
by Eric Christianson | Sep 24, 2023 | Respiratory Medication and Disease State Clinical Pearls
I’m so excited to try something different today and interview one of my great friends! Beth Zerr, PharmD, BCACP was able to share some wisdom on one of the topic areas that she teaches to not only patients but pharmacy students. We cover asthma pharmacology and...
by Eric Christianson | Sep 20, 2023 | Endocrine Medication and Disease State Clinical Pearls
A few months back, I compared one of the newest SGLT2 inhibitors in bexagliflozin to the other agents in this class of medication. To sum up my analysis, bexagliflozin provided nothing significantly different from the other SGLT2 inhibitors. In fact, it has less...
by Eric Christianson | Sep 17, 2023 | Cardiovascular Medication and Disease State Clinical Pearls
ACE Inhibitors have been a workhorse in managing blood pressure for years. While lisinopril is the most commonly used agent that I see in practice, I thought it would be helpful to put together an ACE Inhibitor Comparison table to share with the audience and highlight...
